ITGAM and malaria: BM-MSC administration did not affect spleen histology in uninfected mice (Fig. 3a, b); however, administration of BM-MSCs reduced levels of malaria pigment and increased the CD11b+ cell count in spleens of P. berghei-infected mice (Fig. 3c).